4//SEC Filing
Huntsman Ronald Kirk 4
Accession 0001493152-21-020536
CIK 0001716166other
Filed
Aug 17, 8:00 PM ET
Accepted
Aug 18, 3:47 PM ET
Size
6.9 KB
Accession
0001493152-21-020536
Insider Transaction Report
Form 4
Huntsman Ronald Kirk
DirectorChief Executive Officer10% Owner
Transactions
- Purchase
Common Stock
2021-08-17$3.00/sh+5,000$15,000→ 10,500 total
Holdings
- 1,740,000(indirect: See footnote)
Common Stock
- 333,334
Stock Option (Right to Buy)
Exercise: $1.65Exp: 2022-09-30→ Common Stock (333,334 underlying)
Footnotes (2)
- [F1]Shares held by Coronado V Partners, LLC, of which the reporting person is a member and manager.
- [F2]The option provides for vesting in five equal annual installments beginning on January 15, 2017.
Documents
Issuer
Vivos Therapeutics, Inc.
CIK 0001716166
Entity typeother
Related Parties
1- filerCIK 0001835498
Filing Metadata
- Form type
- 4
- Filed
- Aug 17, 8:00 PM ET
- Accepted
- Aug 18, 3:47 PM ET
- Size
- 6.9 KB